- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Growth Stocks
Global Pharmaceuticals & Biotech Top Growth Stocks
Results
71
71 companies
Axsome Therapeutics
Market Cap: US$7.5b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$151.20
7D
3.9%
1Y
55.1%
Madrigal Pharmaceuticals
Market Cap: US$12.4b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$587.92
7D
6.2%
1Y
70.3%
Zevra Therapeutics
Market Cap: US$484.2m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$8.65
7D
-5.8%
1Y
-8.9%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$104.5b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$448.20
7D
3.1%
1Y
151.8%
Caris Life Sciences
Market Cap: US$6.8b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$25.15
7D
6.1%
1Y
n/a
PharmaResearch
Market Cap: ₩4.2t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩407,500.00
7D
-9.5%
1Y
107.7%
Camurus
Market Cap: SEK 36.1b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 609.50
7D
-0.9%
1Y
8.9%
PharmaEssentia
Market Cap: NT$180.3b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$487.50
7D
7.5%
1Y
-6.1%
Bonesupport Holding
Market Cap: SEK 12.6b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 194.90
7D
-2.1%
1Y
-47.2%
argenx
Market Cap: €48.1b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€785.00
7D
-0.5%
1Y
36.1%
Egetis Therapeutics
Market Cap: SEK 2.1b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.01
7D
-9.9%
1Y
-10.5%
EZZ Life Science Holdings
Market Cap: AU$109.0m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.
EZZ
AU$2.31
7D
-5.3%
1Y
-9.1%
Xiamen Amoytop Biotech
Market Cap: CN¥31.8b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥77.83
7D
1.0%
1Y
6.4%
Biovica International
Market Cap: SEK 156.4m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.55
7D
1.5%
1Y
-74.2%
Legend Biotech
Market Cap: US$5.2b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$27.15
7D
-8.6%
1Y
-36.4%
Mesoblast
Market Cap: AU$3.1b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.38
7D
4.4%
1Y
39.6%
Newron Pharmaceuticals
Market Cap: CHF 344.9m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 17.16
7D
8.6%
1Y
142.0%
Cutia Therapeutics
Market Cap: HK$2.3b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$6.36
7D
-5.6%
1Y
-25.0%
ARS Pharmaceuticals
Market Cap: US$750.3m
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$8.03
7D
9.7%
1Y
-41.4%
Evoke Pharma
Market Cap: US$23.0m
Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.
EVOK
US$10.73
7D
0.4%
1Y
146.7%
LENZ Therapeutics
Market Cap: US$924.9m
Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
LENZ
US$31.94
7D
24.3%
1Y
-11.0%
Soleno Therapeutics
Market Cap: US$2.4b
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
SLNO
US$45.91
7D
-2.8%
1Y
-19.8%
ADMA Biologics
Market Cap: US$4.1b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$18.32
7D
18.8%
1Y
-14.7%
Corcept Therapeutics
Market Cap: US$8.1b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$77.71
7D
3.4%
1Y
31.6%
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥29.6b
A biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of cancer and immunological diseases.
688192
CN¥64.20
7D
-0.4%
1Y
38.5%
Boji Medical TechnologyLtd
Market Cap: CN¥3.9b
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
300404
CN¥10.10
7D
-3.3%
1Y
13.5%
Clinuvel Pharmaceuticals
Market Cap: AU$559.2m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$11.14
7D
2.7%
1Y
-14.8%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥11.9b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥17.14
7D
-1.1%
1Y
3.6%
Ascelia Pharma
Market Cap: SEK 343.7m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 2.68
7D
-4.6%
1Y
-8.7%
Valneva
Market Cap: €652.2m
A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.
VLA
€3.79
7D
0.3%
1Y
100.2%
Longeveron
Market Cap: US$12.8m
A clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.
LGVN
US$0.63
7D
-3.7%
1Y
-68.1%
Eton Pharmaceuticals
Market Cap: US$441.4m
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$15.85
7D
-8.2%
1Y
31.8%
Kiniksa Pharmaceuticals International
Market Cap: US$3.2b
A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.
KNSA
US$41.97
7D
1.4%
1Y
92.5%
Immutep
Market Cap: AU$390.1m
A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.27
7D
-3.6%
1Y
-14.5%
AprilBioLtd
Market Cap: ₩876.1b
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
A397030
₩38,150.00
7D
-4.1%
1Y
143.9%
Oncodesign Precision Medicine Société anonyme
Market Cap: €8.3m
A biopharmaceutical company, engages in the precision medicine business.
ALOPM
€0.46
7D
-0.9%
1Y
-57.2%